Skip to content
Hemp Law Watch
Back to the atlas
No active alertUpdateFederal

Nov. 29: Three medical marijuana companies ask a federal appeals court to halt DEA's supply-chain cutoff, citing lost sales and layoffs

In an emergency motion in the D.C. Circuit, businesses in Utah, Arizona and Oklahoma say DEA guidance barring trade with late applicants conflicts with its own rescheduling rule. They asked for a ruling by Nov. 25.

Hemp Law Watch desk5 min readFederal jurisdictionLog in to save

Authorship warning

One or more sources supporting this report could not be confirmed as the work of a credited author or an identifiable official body. The signals behind that assessment are listed with each source citation below.

Three state-licensed medical marijuana companies have asked a federal appeals court to block a Nov. 29 deadline the Drug Enforcement Administration set for businesses operating under the federal government's partial rescheduling of marijuana. In an emergency motion dated Nov. 18 in the U.S. Court of Appeals for the District of Columbia Circuit, the companies say the deadline is already splitting state medical cannabis markets and could cost them customers, suppliers and jobs they cannot get back. They asked the court for a ruling, or a temporary administrative stay, by Nov. 25.

The petitioners are Standard Wellness Utah, a Utah cultivator and processor; Verde Americano, an Arizona licensee with a Phoenix manufacturing facility and a Rio Rico dispensary; and NW Confections OK 241AA, an Oklahoma processor. The case is Standard Wellness Utah, LLC v. Drug Enforcement Administration, No. 26-1324, and names DEA and Administrator Terrance C. Cole as respondents. Marijuana Moment reported the filing on Nov. 19 and published a copy of the court papers.

What DEA told applicants

The challenge targets a document titled "DEA Medical Marijuana Timely Applicant Information," which the companies say DEA emailed to applicants on Oct. 30, the same day the Justice Department announced the first federal registrations for more than 900 medical marijuana dispensaries in seven states.

The document says businesses that filed complete applications between April 28 and June 26, 2026, which it calls "Timely Applicants," may keep operating under their state medical marijuana licenses while DEA reviews their applications. It says they may trade with other Timely Applicants and with DEA registrants. But it also says Timely Applicants and registrants "may not lawfully engage in any schedule III medical marijuana activities" with businesses that did not apply in that window until those businesses become DEA registrants, and that doing so "could be potential grounds for denial" of an application or revocation of a registration.

The guidance gives businesses time to adjust. It says Timely Applicants "are expected to complete these activities and establish compliant supply chains no later than November 29, 2026." Dispensers and distributors may keep selling inventory they acquired before the guidance was issued. DEA's document also says its contents "do not have the force and effect of law and are not meant to bind the public in any way."

What the companies argue

The companies' motion argues the guidance conflicts with the April rescheduling order and DEA's own regulation. That regulation, 21 C.F.R. 1301.13(k)(7), says an applicant that applied within 60 days of the rule's publication "may engage in the manufacture, distribution, and/or dispensing of marijuana or products containing marijuana for medical purposes in conformity with a state-issued license during the pendency of the application."

"Neither sets a calendar end date, and neither conditions that authority on the status of an applicant's trading partners; it lasts as long as the application is pending," the motion says.

The companies make two more arguments. They say the guidance is a legislative rule that DEA issued without notice and public comment, and that it is arbitrary and capricious because "DEA failed to consider the reliance interests it discarded." The motion also stresses that state medical marijuana markets cannot draw supply from other states.

"This perfunctorily issued deadline ignores the realities of state markets, which prohibit interstate commerce—meaning that operators are entirely dependent on intrastate markets for manufacture, distribution, and dispensing," the motion says.

The numbers in the filing

The motion includes detailed figures on how each company says it would be affected. These are the companies' own claims, made in a court filing; Hemp Law Watch has not seen a DEA response to them.

Standard Wellness Utah is not a Timely Applicant; the motion says it applied in early November. It says the company's sales to 14 pharmacy locations that are Timely Applicants account for about $275,900 a month, or about 38%, of its billed wholesale sales, and that two Utah processors that supply about 16% of its oil are also Timely Applicants. If it cannot find bulk oil, the motion says, the company would cut its staff from 42 to 18. The filing says Utah's medical market, with about 118,000 registered patients, would split into five producers that are Timely Applicants selling to 14 pharmacies, and seven producers that are not.

Verde Americano is a Timely Applicant. The motion says sales to customers that are not Timely Applicants run about $600,000 a month, roughly 40% to 50% of its revenue, and that it will stop selling to them on Nov. 29. It says the company expects to lay off about 95 of its 136 employees.

NW Confections is also a Timely Applicant. The motion says it has identified 15 dispensary customers that are not Timely Applicants, operating about 23 locations, that it will stop serving after Nov. 29, and that it "expects to begin operating at a deficit and to become insolvent" unless its loss of customers stops or reverses. The filing also says Oklahoma's Bureau of Narcotics and Dangerous Drugs has said only that it will not take administrative action before Jan. 1, 2027.

The motion says the market has already reacted. It says one Utah buyer is quarantining about $80,000 of Standard Wellness Utah product, and that two major Verde customers demanded proof of its DEA status while a large customer paused its orders.

According to the filing, the companies asked DEA on Nov. 16 to suspend the deadline and requested an answer by Nov. 17. "As of this filing, the agency has not responded," the motion says.

How we got here

Attorney General Todd Blanche's April rescheduling order placed certain state-licensed medical marijuana activities under Schedule III of the Controlled Substances Act and set up the expedited DEA registration process. On Oct. 30, the Justice Department said the first registrations went to more than 900 dispensaries in Alabama, Florida, Mississippi, South Dakota, Texas, Virginia and West Virginia, and that DEA was still reviewing manufacturer and distributor applications, which require facility inspections, production controls and quota determinations.

DEA has also moved to deny registration to businesses in several states. Marijuana Moment reported that the agency has sent orders to show cause to applicants in California, Delaware, the District of Columbia, Illinois, Minnesota, North Dakota and Oregon.

State regulators have said they have little direct guidance. In a Nov. 18 bulletin, the Massachusetts Cannabis Control Commission shared DEA's Timely Applicant document with licensees and said it "has not received implementation guidance from any federal agencies regarding these developments."

What's next

No DEA response or court ruling had been reported as of Thursday morning. The companies want a decision by Nov. 25, four days before the deadline. Unless the court or DEA acts, the guidance says compliant supply chains are expected by Nov. 29.

Hemp Law Watch covered DEA's first registrations and the Nov. 29 date (https://hemplawwatch.com/article/6ae4ec58f66aa28f7fbe554e) and the agency's moves to deny registration in several states (https://hemplawwatch.com/article/6af4ccb77ef5a936876c2f2a).

This article is news coverage, not legal advice.

Related legal context

Source citation cards

Authorship is reported as a signal for editorial review. Automated checks cannot prove who wrote a document, so every card records what was found and what remains uncertain.

Source 1Source verified

Medical Marijuana Companies Sue DEA In Federal Court Over Restrictions It Imposed For Rescheduling Protections

Publisher
Marijuana Moment
Author
Tom Angell
Published
Nov 19, 2026
Jurisdiction
FEDERAL
Severity
No active alert
Retrieval
HTTP 200
Credited authorOpen source

Authorship signal — The report provides a specific named reporter as credit.

Source 2Source verified

DEA Medical Marijuana Timely Applicant Information

Publisher
U.S. Drug Enforcement Administration
Author
Drug Enforcement Administration
Published
Oct 30, 2026
Jurisdiction
FEDERAL
Severity
No active alert
Retrieval
HTTP 200
Official bodyOpen source

Authorship signal — The document is published by a federal law enforcement agency.

Source 3Source verified

Justice Department Announces Issuance of Federal Registrations for Medical Marijuana Dispensaries

Publisher
U.S. Department of Justice
Author
Office of Public Affairs
Published
Oct 30, 2026
Jurisdiction
FEDERAL
Severity
No active alert
Retrieval
HTTP 200
Official bodyOpen source

Authorship signal — The press release is published by the Department of Justice's Office of Public Affairs.

Source 4Source verified

21 CFR 1301.13, Application for registration; time for application; expiration date; registration for independent activities; application forms, fees, contents and signature; coincident activities

Publisher
National Archives (Office of the Federal Register)
Author
Office of the Federal Register
Published
Nov 19, 2026
Jurisdiction
FEDERAL
Severity
No active alert
Retrieval
HTTP 200
Official bodyOpen source

Authorship signal — The content is hosted on the official Electronic Code of Federal Regulations repository.

Source 5Source verified

Bulletin: Federal Medical Cannabis Rescheduling and DEA Registration Information, November 18, 2026

Publisher
Massachusetts Cannabis Control Commission
Author
Cannabis Control Commission
Published
Nov 18, 2026
Jurisdiction
FEDERAL
Severity
No active alert
Retrieval
HTTP 200
Official bodyOpen source

Authorship signal — The bulletin is issued by a state-level regulatory commission.

Source 6Authorship warning

Standard Wellness Utah, LLC v. DEA, No. 26-1324: Petition for Review and Emergency Motion to Stay

Publisher
Marijuana Moment / DocumentCloud
Author
Blank Rome LLP (counsel for petitioners)
Published
Nov 18, 2026
Jurisdiction
FEDERAL
Severity
No active alert
Retrieval
HTTP 200
Authorship unclearOpen source

Authorship signal — The document is a legal filing hosted on a third-party platform with no primary authorship oversight.

Warning: Authorship is unclear. If this source is relied on, the published report must carry a visible authorship warning.

Discussion

0 comments

Log in to join the discussion. Comments are public and appear with your name.

No comments yet. Be the first to add context.

Hemp Law Watch

A nationwide publication tracking hemp and cannabis law as it changes. Every published report carries its sources, authorship signals and an alert classification.

Sections

Editorial

Alert classifications

  • Federal alert
  • Misdemeanor / ticketable

Hemp Law Watch reports on legal developments and does not provide legal advice. State summaries are editorial reference points reviewed by the desk; always confirm against the cited primary sources.

© 2026 Hemp Law Watch